Cargando…

Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis

INTRODUCTION: Syndrome of inappropriate antidiuresis (SIAD) can be a complication of hypothalamus-pituitary surgery. The use of tolvaptan in this setting is not well established, hence the primary aim of this study was to assess the sodium correction rates attained with tolvaptan compared with stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Indirli, Rita, Ferreira de Carvalho, Júlia, Cremaschi, Arianna, Mantovani, Beatrice, Sala, Elisa, Serban, Andreea Liliana, Locatelli, Marco, Bertani, Giulio, Carosi, Giulia, Fiore, Giorgio, Tariciotti, Leonardo, Arosio, Maura, Mantovani, Giovanna, Ferrante, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181462/
https://www.ncbi.nlm.nih.gov/pubmed/34108941
http://dx.doi.org/10.3389/fendo.2021.689887
_version_ 1783704097058193408
author Indirli, Rita
Ferreira de Carvalho, Júlia
Cremaschi, Arianna
Mantovani, Beatrice
Sala, Elisa
Serban, Andreea Liliana
Locatelli, Marco
Bertani, Giulio
Carosi, Giulia
Fiore, Giorgio
Tariciotti, Leonardo
Arosio, Maura
Mantovani, Giovanna
Ferrante, Emanuele
author_facet Indirli, Rita
Ferreira de Carvalho, Júlia
Cremaschi, Arianna
Mantovani, Beatrice
Sala, Elisa
Serban, Andreea Liliana
Locatelli, Marco
Bertani, Giulio
Carosi, Giulia
Fiore, Giorgio
Tariciotti, Leonardo
Arosio, Maura
Mantovani, Giovanna
Ferrante, Emanuele
author_sort Indirli, Rita
collection PubMed
description INTRODUCTION: Syndrome of inappropriate antidiuresis (SIAD) can be a complication of hypothalamus-pituitary surgery. The use of tolvaptan in this setting is not well established, hence the primary aim of this study was to assess the sodium correction rates attained with tolvaptan compared with standard treatments (fluid restriction and/or hypertonic saline). Furthermore, we compared the length of hospital stay in the two treatment groups and investigated the occurrence of overcorrection and side effects including osmotic demyelination syndrome. METHODS: We retrospectively reviewed 308 transsphenoidal surgical procedures performed between 2011 and 2019 at our hospital. We selected adult patients who developed post-operative SIAD and recorded sodium monitoring, treatment modalities and outcomes. Correction rates were adjusted based on pre-treatment sodium levels. RESULTS: Twenty-nine patients (9.4%) developed post-operative SIAD. Tolvaptan was administered to 14 patients (median dose 15 mg). Standard treatments were employed in 14 subjects (fluid restriction n=11, hypertonic saline n=1, fluid restriction and hypertonic saline n=2). Tolvaptan yielded higher adjusted sodium correction rates (12.0 mmolL(-1)/24h and 13.4 mmolL(-1)/48h) than standard treatments (1.8 mmolL(-1)/24h, p<0.001, and 4.5 mmolL(-1)/48h, p=0.004, vs. tolvaptan). The correction rate exceeded 10 mmolL(-1)/24h or 18 mmolL(-1)/48h in 9/14 and 2/14 patients treated with tolvaptan, respectively, and in no patient who received standard treatments. No side effects including osmotic demyelination occurred. Tolvaptan was associated with a shorter hospital stay (11vs.15 days, p=0.01). CONCLUSIONS: Tolvaptan is more effective than fluid restriction (with or without hypertonic saline) and allows for a shortened hospital stay in patients with SIAD after transsphenoidal surgery. However, its dose and duration should be carefully tailored, and close monitoring is recommended to allow prompt detection of overcorrection.
format Online
Article
Text
id pubmed-8181462
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81814622021-06-08 Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis Indirli, Rita Ferreira de Carvalho, Júlia Cremaschi, Arianna Mantovani, Beatrice Sala, Elisa Serban, Andreea Liliana Locatelli, Marco Bertani, Giulio Carosi, Giulia Fiore, Giorgio Tariciotti, Leonardo Arosio, Maura Mantovani, Giovanna Ferrante, Emanuele Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Syndrome of inappropriate antidiuresis (SIAD) can be a complication of hypothalamus-pituitary surgery. The use of tolvaptan in this setting is not well established, hence the primary aim of this study was to assess the sodium correction rates attained with tolvaptan compared with standard treatments (fluid restriction and/or hypertonic saline). Furthermore, we compared the length of hospital stay in the two treatment groups and investigated the occurrence of overcorrection and side effects including osmotic demyelination syndrome. METHODS: We retrospectively reviewed 308 transsphenoidal surgical procedures performed between 2011 and 2019 at our hospital. We selected adult patients who developed post-operative SIAD and recorded sodium monitoring, treatment modalities and outcomes. Correction rates were adjusted based on pre-treatment sodium levels. RESULTS: Twenty-nine patients (9.4%) developed post-operative SIAD. Tolvaptan was administered to 14 patients (median dose 15 mg). Standard treatments were employed in 14 subjects (fluid restriction n=11, hypertonic saline n=1, fluid restriction and hypertonic saline n=2). Tolvaptan yielded higher adjusted sodium correction rates (12.0 mmolL(-1)/24h and 13.4 mmolL(-1)/48h) than standard treatments (1.8 mmolL(-1)/24h, p<0.001, and 4.5 mmolL(-1)/48h, p=0.004, vs. tolvaptan). The correction rate exceeded 10 mmolL(-1)/24h or 18 mmolL(-1)/48h in 9/14 and 2/14 patients treated with tolvaptan, respectively, and in no patient who received standard treatments. No side effects including osmotic demyelination occurred. Tolvaptan was associated with a shorter hospital stay (11vs.15 days, p=0.01). CONCLUSIONS: Tolvaptan is more effective than fluid restriction (with or without hypertonic saline) and allows for a shortened hospital stay in patients with SIAD after transsphenoidal surgery. However, its dose and duration should be carefully tailored, and close monitoring is recommended to allow prompt detection of overcorrection. Frontiers Media S.A. 2021-05-24 /pmc/articles/PMC8181462/ /pubmed/34108941 http://dx.doi.org/10.3389/fendo.2021.689887 Text en Copyright © 2021 Indirli, Ferreira de Carvalho, Cremaschi, Mantovani, Sala, Serban, Locatelli, Bertani, Carosi, Fiore, Tariciotti, Arosio, Mantovani and Ferrante https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Indirli, Rita
Ferreira de Carvalho, Júlia
Cremaschi, Arianna
Mantovani, Beatrice
Sala, Elisa
Serban, Andreea Liliana
Locatelli, Marco
Bertani, Giulio
Carosi, Giulia
Fiore, Giorgio
Tariciotti, Leonardo
Arosio, Maura
Mantovani, Giovanna
Ferrante, Emanuele
Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
title Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
title_full Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
title_fullStr Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
title_full_unstemmed Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
title_short Tolvaptan in the Management of Acute Euvolemic Hyponatremia After Transsphenoidal Surgery: A Retrospective Single-Center Analysis
title_sort tolvaptan in the management of acute euvolemic hyponatremia after transsphenoidal surgery: a retrospective single-center analysis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181462/
https://www.ncbi.nlm.nih.gov/pubmed/34108941
http://dx.doi.org/10.3389/fendo.2021.689887
work_keys_str_mv AT indirlirita tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT ferreiradecarvalhojulia tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT cremaschiarianna tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT mantovanibeatrice tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT salaelisa tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT serbanandreealiliana tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT locatellimarco tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT bertanigiulio tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT carosigiulia tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT fioregiorgio tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT tariciottileonardo tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT arosiomaura tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT mantovanigiovanna tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis
AT ferranteemanuele tolvaptaninthemanagementofacuteeuvolemichyponatremiaaftertranssphenoidalsurgeryaretrospectivesinglecenteranalysis